BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38201285)

  • 41. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
    Mao R; Liu M; Shu X; Li W; Yan W; Li X
    Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
    [No Abstract]   [Full Text] [Related]  

  • 42. The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
    Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biallelic somatic SMARCA4 mutations in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
    Bailey S; Murray MJ; Witkowski L; Hook E; Hasselblatt M; Crawford R; Foulkes WD; Tischkowitz M; Nicholson JC
    Pediatr Blood Cancer; 2015 Apr; 62(4):728-30. PubMed ID: 25307865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case with sinonasal teratocarcinosarcoma in the nasal cavity and ethmoid sinus.
    Takasaki K; Sakihama N; Takahashi H
    Eur Arch Otorhinolaryngol; 2006 Jun; 263(6):586-91. PubMed ID: 16534629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies.
    Agaimy A; Jain D; Uddin N; Rooper LM; Bishop JA
    Am J Surg Pathol; 2020 May; 44(5):703-710. PubMed ID: 31934917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines.
    Karnezis AN; Chen SY; Chow C; Yang W; Hendricks WPD; Ramos P; Briones N; Mes-Masson AM; Bosse T; Gilks CB; Trent JM; Weissman B; Huntsman DG; Wang Y
    Gynecol Oncol; 2021 Feb; 160(2):568-578. PubMed ID: 33328126
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Nakra T; Kakkar A; Mathur SR; Jain D; Kumar S
    Int J Surg Pathol; 2023 Feb; 31(1):104-109. PubMed ID: 35466749
    [No Abstract]   [Full Text] [Related]  

  • 48. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sinonasal teratocarcinosarcoma: Case report of an unusual neoplasm.
    Chakraborty S; Chowdhury AR; Bandyopadhyay G
    J Oral Maxillofac Pathol; 2016; 20(1):147-50. PubMed ID: 27194879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SWI/SNF-deficient Sinonasal Carcinomas.
    Agaimy A
    Adv Anat Pathol; 2023 Mar; 30(2):95-103. PubMed ID: 36580412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond
    Auguste A; Blanc-Durand F; Deloger M; Le Formal A; Bareja R; Wilkes DC; Richon C; Brunn B; Caron O; Devouassoux-Shisheboran M; Gouy S; Morice P; Bentivegna E; Sboner A; Elemento O; Rubin MA; Pautier P; Genestie C; Cyrta J; Leary A
    Cells; 2020 Jun; 9(6):. PubMed ID: 32575483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.
    Nambirajan A; Jain D
    Semin Diagn Pathol; 2021 Sep; 38(5):83-89. PubMed ID: 34147303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sinonasal teratocarcinosarcoma: a case report.
    Foong YC; Murdolo V; Naiman N; Hepner L; Awad R
    J Med Case Rep; 2017 Jun; 11(1):167. PubMed ID: 28637513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The first case of SMARCA4-deficient sarcoma of stomach.
    Ota T; Ishikawa T; Yasuda R; Yasuda T; Okayama T; Inoue K; Dohi O; Yoshida N; Kamada K; Uchiyama K; Takagi T; Konishi H; Naito Y; Matsuyama K; Yamaguchi T; Ootsuka K; Yoshida A; Kishimoto M; Itoh Y
    Clin J Gastroenterol; 2022 Jun; 15(3):531-536. PubMed ID: 35175571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4.
    Ramos P; Karnezis AN; Craig DW; Sekulic A; Russell ML; Hendricks WP; Corneveaux JJ; Barrett MT; Shumansky K; Yang Y; Shah SP; Prentice LM; Marra MA; Kiefer J; Zismann VL; McEachron TA; Salhia B; Prat J; D'Angelo E; Clarke BA; Pressey JG; Farley JH; Anthony SP; Roden RB; Cunliffe HE; Huntsman DG; Trent JM
    Nat Genet; 2014 May; 46(5):427-9. PubMed ID: 24658001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pathological characteristics and immune microenvironment of SMARCA4-deficient undifferentiated uterine sarcoma.
    Gao J; Fan R; Chen D; Hou J; Chen H; Lu M
    Diagn Pathol; 2023 May; 18(1):62. PubMed ID: 37194064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
    Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
    Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sinonasal teratocarcinosarcoma treated with surgery and proton beam therapy: clinical, histological aspects and differential diagnosis of a new case.
    Belotti A; Carpenito L; Bulfamante AM; Maccari A; Bulfamante G
    Pathologica; 2021 Dec; 113(6):469-474. PubMed ID: 34974554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers.
    Tagal V; Wei S; Zhang W; Brekken RA; Posner BA; Peyton M; Girard L; Hwang T; Wheeler DA; Minna JD; White MA; Gazdar AF; Roth MG
    Nat Commun; 2017 Jan; 8():14098. PubMed ID: 28102363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutaneous metastasis of SMARCA4-deficient thoracic sarcoma: A diagnostic dilemma with therapeutic implications.
    Leckey BD; Selim MA; Al-Rohil RN
    J Cutan Pathol; 2020 Jun; 47(6):561-565. PubMed ID: 31995235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.